Acta Chir Orthop Traumatol Cech. 2010; 77(2):118-123 | DOI: 10.55095/achot2010/022

Is Kaplan-Meier Statistics the Most Appropriate Tool for Survivorship Measurement of Outcomes in Orthopaedics?Original papers

K. LANGOVÁ1, J. GALLO2,*
1 Ústav lékařské biofyziky LF UP v Olomouci
2 Ortopedická klinika LF UP a FN, Olomouc

PURPOSE OF THE STUDY:
An assessment of the results over a time period is an integral part of any treatment evaluation. A standard method used for this purpose is Kaplan-Meier survival analysis. The aim of this study was to show how, for total hip arthroplasty (THA), estimates of prosthesis survival probability can be affected by a factor known as competing events.

MATERIAL AND METHODS:
A set of input data concerning competing events (death and loss to follow-up), in addition to the investigated event (revision THA), was analysed by both the Kaplan-Meier method and the method of cumulative incidence with the use of worst-case analysis.

RESULTS:
Our results showed that, for the same input data, the Kaplan-Meier method gave lower estimates of prosthesis survival probability than the method of cumulative incidence. This difference increased with an increasing number of competing events occurring during the clinical study, and with an increasing duration of follow-up. These survival probability estimates can markedly be influenced by the use of worst-case analysis In our set of data this was more than 30 %.

DISCUSSION:
Reports in the orthopaedic literature still show a predominant use of the Kaplan-Meier method, although it is obvious that this is not always optimal for observational clinical studies. Also, it is not clear how beneficial is the use of worst-case analysis, because our and other authors' results suggest that not all patients lost to follow-up should be considered as failed. Therefore, insolvement of such analysis might markedly distort the real survival curves and to disadvantage evaluated the orthopaedic method.

CONCLUSIONS:
In observational clinical studies involving a higher number of competing events, it is preferable to use the cumulative incidence method rather than Kaplan Meier analysis for statistical evaluation of the results. The former gives more exact estimates of prosthesis survival probability. It is also recommended to avoid modifying survival curves indiscriminately according to the results of worst-case analysis.

Keywords: evaluation, survival analysis, Kaplan-Meier method, cumulative incidence, worst-case analysis, competing events, total joint replacement

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
LANGOVÁ K, GALLO J. Is Kaplan-Meier Statistics the Most Appropriate Tool for Survivorship Measurement of Outcomes in Orthopaedics? Acta Chir Orthop Traumatol Cech. 2010;77(2):118-123. doi: 10.55095/achot2010/022. PubMed PMID: 20447354.
Download citation

References

  1. BHANDARI, M., GUYATT, G. H., SWIONTKOWSKI, M. F.: User's guide to the orthopaedic literature: how to use an article about a surgical therapy. J. Bone Jt Surg., 83-A: 916-926, 2001. Go to original source... Go to PubMed...
  2. BIAU, D. J., LATOUCHE, A., PORCHER, R.: Competing events influence estimated survival probability: when is Kaplan-Meier analysis appropriate? Clin. Orthop., 462: 229-233, 2007. Go to original source... Go to PubMed...
  3. BRADBURN, M. J., CLARK, T. G., LOVE, S. B., ALTMAN, D. G.: Survival analysis part II: multivariate data analysis-an introduction to concepts and methods. Brit. J. Cancer, 89: 431-436, 2003. Go to original source... Go to PubMed...
  4. CLARK, T. G., BRADBURN, M. J., LOVE, S. B., ALTMAN, D. G.: Survival analysis part I: basic concepts and first analyses. Brit. J. Cancer, 89: 232-238, 2003. Go to original source... Go to PubMed...
  5. GALLO, J., LANDOR, I., CECHOVA, I., JAHODA, D.: Comparison of Hydroxyapatite-coated stems in total hip arthroplasty after a minimum 10-years follow-up. Acta Chir. orthop. Traum. čech., 75: 339-346, 2008. Go to original source...
  6. GALLO, J., LANGOVA, K., HAVRANEK, V., CECHOVA, I.: Poor survival of ABG I hip prosthesis in younger patients. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc, Czech Repub., 152: 163-168, 2008. Go to original source... Go to PubMed...
  7. GOOLEY, T. A., LEISENRING, W., CROWLEY, J., STORER, B. E.: Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat. Med., 18: 695-706, 1999. Go to original source...
  8. CHEN, B. E., KRAMER, J. L., GREENE, M. H., ROSENBERG, P. S.: Competing risks analysis of correlated failure time data. Biometrics, 64: 172-179, 2008. Go to original source... Go to PubMed...
  9. JOSHI, A. B., GILL, G. S., SMITH, P. L.: Outcome in patients lost to follow-up. J. Arthroplasty, 18: 149-153, 2003. Go to original source... Go to PubMed...
  10. KAPLAN, E. L., MEIER P.: Nonparametric Estimation from Incomplete Observations. J. Amer. Stat. Assoc., 53: 457-481, 1958. Go to original source...
  11. LANGOVA, K.: Survival analysis for clinical studies. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc, Czech Repub., 152: 303-307, 2008. Go to original source... Go to PubMed...
  12. MAKELA, K. T., ESKELINEN, A., PULKKINEN, P., PAAVOLAINEN, P., REMES, V.: Total hip arthroplasty for primary osteoarthritis in patients fifty-five years of age or older. An analysis of the Finnish arthroplasty registry. J. Bone Jt Surg., 90-A: 2160-2170, 2008. Go to original source... Go to PubMed...
  13. MURRAY, D. W., BRITTON, A. R., BULSTRODE, C. J.: Loss to follow-up matters. J. Bone Jt Surg., 79-B: 254-257, 1997. Go to original source...
  14. ROWLEY, D. I., McGURTY, D. W.: A seven-year experience of data collection on the Insall-Burstein II total knee arthroplasty. A prospective study. J. Bone Jt Surg., 83-B: 185-190, 2001. Go to original source...
  15. ROZKYDAL, Z., JANÍČEK, P., TOMÁŠ, T., FLORIAN, Z.: Dlouhodobé výsledky CLS jamky u primární náhrady kyčle. Acta Chir. orthop. Traum. čech., 76: 90-97, 2009. Go to original source...
  16. ROZKYDAL, Z., JANÍK, P., JANÍČEK, P., KUNOVSKÝ, R.: Revizní náhrada kolena po aseptickém uvolnění. Acta Chir. orthop. Traum. čech., 74: 5-13, 2007. Go to original source...
  17. SKUTEK, M., BOURNE, R. B., RORABECK, C. H., BURNS, A., KEARNS, S., KRISHNA, G.: The twenty to twenty-five-year outcomes of the Harris design-2 matte-finished cemented total hip replacement. A concise follow-up of a previous report. J. Bone Jt Surg., 89-A: 814-818, 2007. Go to original source... Go to PubMed...
  18. SPRINGER, B. D., FEHRING, T. K., GRIFFIN, W. L., ODUM, S. M., MASONIS, J. L.: Why revision total hip arthroplasty fails. Clin. Orthop., 467: 166-173, 2009. Go to original source... Go to PubMed...
  19. TOMS, A. D., ISBISTER, E. S.: The evidence base on the orthopaedic NICE report. Hosp. Med., 64: 572-573, 2003. Go to original source... Go to PubMed...
  20. ULRICH, S. D., SEYLER, T. M., BENNETT, D., DELANOIS, R. E., SALEH, K. J., THONGTRANGAN, I., KUSKOWSKI, M., CHENG, E. Y., SHARKEY, P. F., PARVIZI, J., STIEHL, J. B., MONT, M. A.: Total hip arthroplasties: what are the reasons for revision? Int. Orthop., 32: 597-604, 2008. Go to original source... Go to PubMed...
  21. UTLEY, M., GALLIVAN, S., YOUNG, A., COX, N., DAVIES, P., DIXEY, J., EMERY, P., GOUGH, A., JAMES, D., PROUSE, P., WILLIAMS, P., WINFIELD, J., DEVLIN, J. A.: Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies. Rheumatology (Oxford), 39: 1-2, 2000. Go to original source... Go to PubMed...
  22. VAVŘÍK, P., LANDOR, I., DENK, F.: Klinické zhodnocení použití keramické femorální komponenty v konstrukci náhrady kolenního kloubu. Acta Chir. orthop. Traum. čech., 75: 436-442, 2008. Go to original source...
  23. VAVŘÍK, P., LANDOR, I., TOMAIDES, J., POPELKA, S.: Střednědobé výsledky u náhrad kolenního kloubu Medin Modular. Acta Chir. orthop. Traum. čech., 76: 30-34, 2009. Go to original source...
  24. WEI, L. J., GLIDDEN, D. V.: An overview of statistical methods for multiple failure time data in clinical trials. Stat. Med., 16: 833-839, 1997. Go to original source...